• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137

tetano

Editor, Senior Moderator
Appl Microbiol Biotechnol. 2020 Jan 2. doi: 10.1007/s00253-019-10217-2. [Epub ahead of print] [h=1]A new abyssomicin polyketide with anti-influenza A virus activity from a marine-derived Verrucosispora sp. MS100137.[/h]
Zhang J[SUP]1[/SUP], Li B[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Qin Y[SUP]3[/SUP], Karthik L[SUP]1,[/SUP][SUP]4[/SUP], Zhu G[SUP]1[/SUP], Hou C[SUP]1[/SUP], Jiang L[SUP]1[/SUP], Liu M[SUP]5[/SUP], Ye X[SUP]3[/SUP], Liu M[SUP]3[/SUP], Hsiang T[SUP]6[/SUP], Dai H[SUP]7[/SUP], Zhang L[SUP]8[/SUP], Liu X[SUP]9[/SUP].
[h=3]Author information[/h] 1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. 2 Institute of Physical Science and Information Technology, Anhui University, Hefei, 230601, Anhui Province, China. 3 Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. 4 Sri Shakthi Institute of Engineering and Technology (Autonomous), Coimbatore, Tamil Nadu, India. 5 Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia. 6 School of Environmental Sciences, University of Guelph, Guelph, Ontario, N1G 2W1, Canada. 7 Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. daihq@im.ac.cn. 8 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. lxzhang@ecust.edu.cn. 9 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, 200237, China. liuxueting@ecust.edu.cn.

[h=3]Abstract[/h] Marine microorganisms live in dramatically different environments and have attracted much attention for their structurally unique natural products with potential strong biological activity. Based on the one strain-many compounds (OSMAC) strategy and liquid chromatography mass spectrometry (LC-MS) methods, our continuing efforts on the investigation of novel active compounds from marine Verrucosispora sp. MS100137 has led to the identification of a new polycyclic metabolite, abyssomicin Y (1), together with six known abyssomicin and proximicin analogs (2-7). Abyssomicin Y is a type I abyssomicin with an epoxide group at C-8 and C-9. Compounds 1-3 showed potent inhibitory effects against the influenza A virus; their observed inhibition rates were 97.9%, 98.3%, and 95.9%, respectively, at a concentration of 10 μM, and they displayed lower cytotoxicity than 4. The structures were determined by different NMR techniques and HRMS experiments. This investigation revealed that OSMAC could serve as a useful method for enabling the activation of the silent genes in the microorganism and for the formation of previously unreported active secondary metabolites.


[h=4]KEYWORDS:[/h] Abyssomicin; Anti-influenza A virus; Marine-derived Verrucosispora sp.; OSMAC; Proximicin

PMID: 31894364 DOI: 10.1007/s00253-019-10217-2
 
Back
Top Bottom